Cargando…
The Association between Dialysis Dose and Risk of Cancer Death in Patients Undergoing Hemodialysis: The Q-Cohort Study
OBJECTIVE: Uremic toxins are known risk factors for cancer in patients undergoing hemodialysis (HD). Although adequate removal of uremic toxins might reduce the cancer risk by improving subclinical uremia, the relationship between the dialysis dose and risk of cancer death in patients undergoing HD...
Autores principales: | Hara, Masatoshi, Tanaka, Shigeru, Taniguchi, Masatomo, Fujisaki, Kiichiro, Torisu, Kumiko, Nakano, Toshiaki, Tsuruya, Kazuhiko, Kitazono, Takanari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270758/ https://www.ncbi.nlm.nih.gov/pubmed/32051383 http://dx.doi.org/10.2169/internalmedicine.4027-19 |
Ejemplares similares
-
Prognostic value of pre-dialysis blood pressure and risk threshold on clinical outcomes in hemodialysis patients: The Q-Cohort Study
por: Hara, Masatoshi, et al.
Publicado: (2018) -
The Incidence and Associated Factors of Sudden Death in Patients on Hemodialysis: 10-Year Outcome of the Q-Cohort Study
por: Hiyamuta, Hiroto, et al.
Publicado: (2020) -
Sex differences in the 10-year survival of patients undergoing maintenance hemodialysis in the Q-Cohort Study
por: Tsujikawa, Hiroaki, et al.
Publicado: (2022) -
Asymptomatic Brain Edema after Hemodialysis Initiation in a Patient with Severe Uremia
por: Fujisaki, Kiichiro, et al.
Publicado: (2017) -
Development of a risk prediction model for infection-related mortality in patients undergoing peritoneal dialysis
por: Tsujikawa, Hiroaki, et al.
Publicado: (2019)